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Background: It can be difficult to register a weak proliferative response of T lymphocytes to an antigen, particularly
in a simple culture system of peripheral blood mononuclear cells (PBMC). Here we assess the usefulness of the
cytokine IL-2 in amplifying such a response.
Methods: PBMC from healthy donors were cultured in the presence or absence of keyhole limpet haemocyanin
(KLH), an antigen to which people have not been previously exposed. IL-2 was added from the beginning or on
the fifth day of culture. Proliferation was determined by incorporation of tritiated thymidine at eight days. The recall
antigen, tuberculin PPD, provided a positive control.
Results: IL-2 added at the beginning of culture can induce extremely high levels of proliferation even in the
absence of antigen. However, when added on the fifth day it allowed the clear observation of a proliferative
response to KLH that was barely detectable in its absence. Added late it was similarly able to boost low responses
to PPD and to the mitogens lipopolysaccharide and poly(I:C), but it had no such effect with pokeweed mitogen.
Conclusions: IL-2 added late in culture is highly effective in increasing the sensitivity of T lymphocyte proliferative
assays.
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It can sometimes be difficult to identify the presence of
antigen-reactive T lymphocytes by assaying for antigen-
induced proliferation of the cells. There are many reasons
why this may be so. The number of reactive cells may be
too small. Moreover, they may be in an anergic state or
under the influence of regulatory T cells. There may be
'noise', that is the proliferation in culture of cells other
than those being assayed. The problem may also be one
of inappropriate antigen presentation or simply that the
culture conditions are sub-optimal.
Some of these problems may be circumvented by puri-
fication of cell populations but this will inevitably detract
from ease of assay. Another and attractive approach is to
make use of the ability of the cytokine IL-2 to interact
with T lymphocytes and augment cell division only after
the lymphocytes have first been activated by recognition
of antigen [1]. The activated cells express a high affinity* Correspondence: m.salaman@imperial.ac.uk
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unless otherwise stated.receptor for IL-2 and proliferate in response to that
cytokine. Although much use has been made of this
property in the development of T cell lines and clones
[2], it has not been widely used for assay amplification
[3,4]. Other cytokines have been considered for such
amplification [4] (see Discussion), but IL-2 is by far the
best understood and most readily available cytokine with
the required property.
It is notoriously difficult to obtain a primary proliferative
response to an exogenous antigen in a simple culture of
peripheral blood mononuclear cells (PBMC) [5,6]. In this
paper we have attempted to get around the difficulties
experienced with PBMC by amplifying proliferation
through the addition of IL-2. We have studied the effect
of added IL-2 on the response to keyhole limpet haemo-
cyanin (KLH), an antigen with which people will have
had no previous contact. By way of a positive control
we have also tested the effect of IL-2 on the recall
response to tuberculin PPD, a response which is not in
need of amplification.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Spontaneous lymphocyte proliferation in the
presence of IL-2 added either at the beginning or
towards the end of culture
Lymphocyte proliferation (cpm)
Donor No IL-2 IL-2 (60 i.u./ml) added IL-2 (600 i.u./ml) added
Day 0 Day 5 Day 0 Day 5
M1 67 10306 - 28138 206
F1 66 17645 221 46194 238
F2 127 2091 160 - -
F4 92 934 125 - -
F5 105 866 128 - -
PBMC from one male and four female donors were cultured at 0.15 × 106 cells/
ml for eight days. IL-2 at a final concentration of 60 or 600 i.u./ml was added
either at the start of culture or after 5 days. Tritiated thymidine was present
for the final 18 h of culture and mean values of thymidine uptake are shown.
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Antigens and mitogens
Keyhole limpet haemocyanin (KLH) was obtained from
Sigma, Poole, UK (H7017). The 20 mg samples were taken
up in 2 ml of sterile distilled water and diluted further
with phosphate buffered saline (PBS) to 1 mg/ml. This
was aliquoted and stored at −20°C.
Purified protein derivative (PPD), a freeze dried prep-
aration of bovine tuberculin, was obtained from the
Veterinary Laboratories Agency, Addlestone, UK. It was
dissolved at 1 mg/ml in RPMI medium (see below) and
sterilised by filtration. Aliquots were stored at −20°C.
Lipopolysaccharide (LPS), derived from E.coli 055:B5,
came from Sigma (L-6529) as did pokeweed mitogen
and poly(I:C).
Culture of blood mononuclear cells (PBMC)
Blood was taken from healthy staff in the Department
of Immunology at the St Mary's Campus of Imperial
College School of Medicine. Fully informed verbal consent
was obtained from all blood donors; the study design and
consent was approved by St Mary's Local Research Ethics
Committee. The Ethics Committee did not ask for the
verbal consent to be recorded.
Samples (20 ml) were donated on multiple occasions by
one male donor (M1) and five females (F1 - F5). The blood
was taken into preservative-free heparin (20 units/ml), and
PBMC were obtained by centrifugation on Histopaque-
1077 (Sigma) of the blood diluted 1:1 with RPMI-1640
(Dutch Modification, Sigma R7638). The separated cells
were taken up in culture medium, RPMI medium supple-
mented with 2 mM L-glutamine, 10 μg/ml gentamycin
(Mayne Pharma, Warwickshire, UK) and 5% human AB
serum (Sigma H-4522) at 0.15 × 106 cells/ml.
Aliquots (1 ml) of the cells received 10 μl of appropri-
ately diluted antigen/mitogen as required. Five replicate
cultures of 0.18 ml were then set up from each aliquot
in 96-well round-bottom culture plates (Nunc, Roskilde,
Denmark). One control group without any antigen/
mitogen was set up on each plate and up to 3 plates were
set up on a given day. Plates were incubated in a humid
atmosphere of 5% CO2 at 37°C for 8 days. After 5 days of
culture all wells (unless indicated) received 5 μl of
IL-2 to give a final concentration of 60 international units
(i.u.)/ml. Recombinant human IL-2 was a kind gift from
the Cetus Corporation (Emeryville, CA, USA).
Eighteen hours before termination of culture each well
received 0.5 μCi of [methyl-3H] thymidine at 2 Ci/mmol
(TRA310; Amersham Biosciences, Little Chalfont, UK).
Uptake of thymidine into DNA was determined using a
Packard system (Perkin Elmer, Mass. USA) involving
filtration of lysed cells onto 96-well filter plates (UniFilter
GF/C), addition of scintillant (MicroScint O) to each well
followed by counting in a TopCount. The geometric meanof the five replicates was calculated. The value of the
factor which on multiplication and division of the mean
gives the range of one standard deviation generally fell
between 1.1 and 2.2.
Results
With the objective of increasing the sensitivity of the
lymphocyte proliferation assay, we began by testing the
effect of adding IL-2 to cultures in the absence of antigen.
Table 1 shows five experiments in which IL-2 was added
either at the start of the eight days of culture or after five
days. In each experiment the mean uptake of tritiated
thymidine at the end of culture was greatly enhanced
when IL-2 had been present from the beginning. This
was particularly marked for donors M1 and F1, the high
level of response to IL-2 being confirmed in repeat experi-
ments with these donors. Other female donors showed
more modest enhancement.
When, however, addition of IL-2 was delayed until Day
5 only a small increase in baseline incorporation occurred.
As will be seen, Day 5 addition of IL-2 was successful in
boosting proliferation in the presence of antigen and
therefore became the adopted procedure. The level of
IL-2 chosen was 60 i.u./ml. Although 600 i.u./ml added
from the beginning appeared more effective than 60
i.u./ml in the absence of antigen (Table 1), there was
little difference in their effects with or without antigen
when added on Day 5.
The amplified assay was tested using KLH as an antigen
to which the donors had not been exposed previously
(Table 2). KLH was tested at levels from 0.01 to 10 μg/ml
but in any one experiment the concentration range did
not exceed 100-fold. In the absence of IL-2, antigen
responses were clearly too small and inconsistent to allow
any definite conclusions. By contrast, in the presence of
IL-2, clear-cut responses to KLH were seen at both 1 and
10 μg/ml, with evidence that the response peaks at about
1 μg. Even at 0.1 μg/ml responses could be detected.
Table 2 IL-2 amplification of proliferation assay
Lymphocyte proliferation (cpm)
KLH (μg/ml) KLH (μg/ml) + IL-2 PPD PPD +
IL-2Donor No antigen 0.01 0.1 1 10 No antigen 0.01 0.1 1 10
M1 148 - 203 568 376 175 - 1981 2676 2004 6358c 17702
M1 72 70 90 104 - 163 437 1253 1070 - 1426b 8431
M1 108 - 113 128 279 221 - 429 1732 1178 419a 4846
F2 71 90 139 1241 - 123 212 380 2969 - 9233c 16818
F3 83 - 93 239 - 115 - 569 1163 - 216b 1691
F4 90 102 86 175 - 148 124 283 521 - 965b 5284
Mean values of thymidine uptake are shown for one male and three female donors in a total of six experiments. PBMC were cultured at 0.15 × 106 cells/ml. IL-2 at
60 i.u./ml was added, where indicated, after 5 days. KLH or PPD were present from the start of culture as shown. PPD concentration in the different experiments is
indicated by (a) 0.1, (b) 1 or (c) 10 μg/ml.
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was used as a positive control. Provided that the donor is
tuberculin-positive and a sufficiently high concentration
of PPD is used there is no need for exogenous IL-2 in
order to get a good response. Nevertheless, proliferation
was strongly enhanced by IL-2 in each case (Table 2). If
the effectiveness of IL-2 is expressed as the ratio of mean
thymidine incorporation in the presence of PPD and IL-2
over mean incorporation with PPD alone, when the latter
is high (first and fourth experiments) the enhancement
ratio was around 2–3 fold. But when the response without
IL-2 was more modest, the ratio ranged from 5–12.
The corresponding values for KLH were expressed as
geometric mean ratios at each level of the antigen. The
mean values for donor M1 were used to calculate an
overall mean for the four donors. Mean ratios were
between 4–5 for KLH concentrations of 0.1, 1.0 or
10 μg/ml. Thus, where PPD responses in the absence of
IL-2 were comparable to those of KLH, the enhancing effect
of IL-2 appears at least as great for PPD as it was for KLH.
Several experiments of the type reported in Table 2
were carried out using lipopolysaccaride (LPS) in place
of antigen. In the presence of IL-2 clear responses were
observed at LPS levels down to at least 0.001 μg/ml,
though the magnitude of the responses was not great.
Even at 1 μg/ml the level of response was only around
1000 cpm. The IL-2 enhancement ratios were comparable
to those seen with KLH, and this was also true of
responses to poly(I:C) (0.2 - 2 μg/ml). Pokeweed mitogen
was the only stimulatory agent used not to show clear
IL-2 enhancement. The results for four different donors
in the presence of pokeweed mitogen (10 μg/ml) were
8690 cpm (IL-2 absent)/8453 cpm (IL-2 present), 5832/
9320, 23089/25713, and 2245/1403, giving a mean en-
hancement ratio of 1.02.
Discussion
In this paper we have demonstrated the ability of added
IL-2 to enhance low proliferative responses to KLH in aPBMC system. It is most important to add the IL-2
towards the end of the culture period. In confirmation
of earlier studies by Taylor et al. [7], added from the
beginning it induces high levels of proliferation in the
absence of antigen because of the presence of activated T
cells circulating in the blood. In the absence of IL-2 these
cells evidently either die or lose their active status during
the course of incubation. Preliminary data suggest that
exceptionally high responses to IL-2 added from the
beginning may be a characteristic of particular donors
rather than being due to an acute infection. A similar
assay system involving late addition of IL-2 has been
proposed for use with mouse lymph node cells [8].
With IL-2 added after 5 days there was little effect
on background proliferation and we were able to see a
proliferative response to KLH at levels from 0.1 to
10 μg/ml (peaking at 1 μg) that was not observable in
the absence of IL-2. Enhancement by IL-2 was also
seen with the recall antigen PPD, the magnitude of the
effect being similar to that for KLH when the response
in the absence of IL-2 was low. It is of course well
known that the proliferative response to PPD is a T
cell response and this appears also to be the case for
KLH [9]. Moreover, the T cell nature of these responses is
further supported by the finding in preliminary experiments
of inhibition of the KLH and PPD responses by antibodies
against co-stimulatory molecules B7-1 and B7-2 [10]. It
seems then that IL-2 enhancement can play a vital role
where T cell proliferation is otherwise too low for assay
purposes.
The mitogenic effects of LPS and poly(I:C) were like-
wise augmented by IL-2 to a similar extent as for KLH.
This observation may suggest that the predominant
proliferating cell here was the T cell, and these agents
are known to be able to interact with T cells either
directly or through their stimulation of other cell types
[11,12]. It would be expected that the magnitude of the
IL-2 effect is independent of the mechanism of T cell
activation. The failure of pokeweed mitogen to show
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directly mitogenic for both B and T cells [13] and appears
to have a role in promoting B cell growth [14]. The
explanation may lie in an exceptionally strong IL-2
response induced in PBMC by pokeweed mitogen [15],
making exogenous IL-2 redundant.
The level of IL-2 used for amplification (60 i.u. or
3.3 ng/ml) appears high in relation to physiological levels.
PBMC from BCG-vaccinated infants stimulated with PPD
produced a mean of 17 pg/ml [16] and similar values with
adult cells have been obtained for PHA stimulation [15].
A wide range of serum levels have been reported from
undetectable to low nanogram quantities per ml. Clearly
any IL-2 provided by the 5% serum in our cultures is not
sufficient to induce significant proliferation.
Munier and colleagues [4] have investigated a similar
approach for boosting low responses in PBMC to viral
antigens. Their aim was to boost low secondary responses
rather than to enable a primary response to be detected.
Proliferation was assessed by a flow cytometric technique
and, as might be expected, when IL-2 was added after
three days of a ten day culture major enhancement
occurred in the absence of viral antigen. Background
proliferation was reduced when IL-2 was added after five
days, but the best conditions for augmentation of responses
were obtained not with IL-2 but with a combination of
IL-15 and IL-21 added after five days.
We have seen that IL-2 added late in culture of PBMC is
excellent at boosting antigen-induced T cell proliferation.
That the procedure enables the measurement of a response
to KLH and augments the response to PPD implies that
it is effective in both primary and secondary responses.
However, it will be important to confirm the action on
primary responses using highly purified antigen systems.
The procedure should be useful in studying the immune
response to microorganisms including the field of vaccine
development. Also, if the efficacy in primary response
is confirmed, it could be applied to the study of the
pathogenesis of autoimmune disease where the self-
antigens involved may never under normal conditions
interact with lymphocytes to induce either tolerance or an
immune response [17]. Such purified self-antigens should
in principle give rise to a primary response in cultures
of PBMC from healthy donors as well as producing a
secondary response in patients.Conclusions
This study demonstrates the striking ability of IL-2 added
late in culture of PBMC to stimulate antigen-initiated T
lymphocyte proliferation. Such an approach should be
of great help where weak antigen responses are being
assayed, in particular in the fields of infectious and
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